Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
FGEN FibroGen
- 0.480
- +0.080+20.00%
Close Dec 23 16:00 ET
- 0.470
- -0.010-2.04%
Post 16:11 ET
48.37MMarket Cap-0.39P/E (TTM)
0.480High0.400Low2.59MVolume0.410Open0.400Pre Close1.16MTurnover2.79%Turnover RatioLossP/E (Static)100.77MShares2.93052wk High-0.20P/B44.60MFloat Cap0.18052wk Low--Dividend TTM92.91MShs Float68.550Historical High--Div YieldTTM20.00%Amplitude0.180Historical Low0.449Avg Price1Lot Size
FibroGen Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.45%46.33M | 14.26%50.64M | 54.59%55.9M | 4.99%147.75M | -21.03%27.14M | 155.06%40.13M | 48.69%44.32M | -40.55%36.16M | -40.19%140.73M | 107.74%34.37M |
| Operating revenue | 4.85%58.17M | -16.50%54.4M | 47.93%72.59M | 4.99%147.75M | -863.18%-21.95M | 67.95%55.48M | 71.05%65.14M | -26.47%49.07M | -40.19%140.73M | 108.34%2.88M |
| Cost of revenue | 24.79%5.3M | -9.29%5.18M | 637.70%25.75M | -7.06%18.85M | 9.79%5.41M | -1.51%4.24M | -16.17%5.71M | -17.63%3.49M | 57.56%20.28M | 57.60%4.93M |
| Gross profit | 14.34%41.04M | 17.75%45.46M | -7.72%30.15M | 7.02%128.9M | -26.19%21.73M | 214.09%35.89M | 67.90%38.61M | -42.27%32.67M | -45.85%120.45M | 119.42%29.44M |
| Operating expense | -54.75%39.26M | -55.49%56.38M | -43.72%61.21M | -5.54%398.11M | -20.57%75.93M | -17.43%86.77M | 25.13%126.66M | -9.05%108.76M | -17.51%421.48M | -35.70%95.59M |
| Selling and administrative expenses | -31.36%17.55M | -28.56%22.28M | -33.42%22.82M | -7.57%115.25M | -28.68%24.22M | -14.48%25.57M | 3.05%31.18M | 12.14%34.28M | 0.62%124.69M | -2.23%33.97M |
| Research and development costs | -64.53%21.71M | -64.28%34.11M | -48.46%38.39M | -4.69%282.86M | -16.10%51.7M | -18.61%61.19M | 34.55%95.48M | -16.32%74.49M | -23.32%296.79M | -45.90%61.63M |
| Operating profit | 103.49%1.78M | 87.60%-10.92M | 59.18%-31.06M | 10.57%-269.21M | 18.08%-54.2M | 45.68%-50.88M | -12.56%-88.05M | -20.79%-76.09M | -4.33%-301.03M | 51.09%-66.15M |
| Net non-operating interest income expense | -64.19%-1.19M | -1,354.20%-6.06M | -81.59%-2.43M | -182.07%-5.05M | -1,218.97%-2.57M | -142.36%-726K | -108.24%-417K | -218.85%-1.34M | 385.93%6.16M | -120.92%-195K |
| Non-operating interest income | -11.50%3.8M | ---- | 148.07%2.57M | 37.97%10.48M | 170.13%2.5M | 138.93%4.3M | -48.99%2.65M | --1.04M | --7.6M | --924K |
| Non-operating interest expense | -0.56%4.99M | 97.59%6.06M | 110.62%5M | 978.61%15.53M | 352.90%5.07M | 5,878.57%5.02M | 2,076.60%3.07M | 466.11%2.37M | -33.12%1.44M | 220.06%1.12M |
| Other net income (expense) | -47.18%-18.55M | -12.61M | 0 | -12.61M | ||||||
| Special income (charges) | -47.18%-18.55M | ---- | ---- | ---12.61M | --0 | ---12.61M | ---- | ---- | --0 | --0 |
| -Less：Restructuring and merger&acquisition | 47.18%18.55M | ---- | ---- | --12.61M | --0 | --12.61M | ---- | ---- | --0 | --0 |
| Income before tax | 72.01%-17.97M | 80.80%-16.98M | 56.75%-33.49M | 2.71%-286.87M | 14.44%-56.77M | 30.17%-64.21M | -20.91%-88.47M | -22.10%-77.43M | -1.44%-294.87M | 50.60%-66.35M |
| Income tax | -85.71%12K | -11.49%-262K | -55.41%33K | -99.16%3K | -25.93%80K | -26.32%84K | -1,121.74%-235K | -34.51%74K | 3.17%358K | -3.57%108K |
| Earnings from equity interest net of tax | 32.64%898K | 114.00%1.18M | -26.01%589K | 67.71%2.64M | 119.64%615K | 66.34%677K | -2.65%550K | 148.75%796K | 56.21%1.57M | -18.37%280K |
| Net income | 73.14%-17.08M | 82.27%-15.54M | 57.07%-32.93M | 3.21%-284.23M | 15.03%-56.23M | 30.59%-63.62M | -20.73%-87.68M | -21.36%-76.71M | -1.25%-293.65M | 50.64%-66.18M |
| Net income continuous Operations | 73.14%-17.08M | 82.27%-15.54M | 57.07%-32.93M | 3.21%-284.23M | 15.03%-56.23M | 30.59%-63.62M | -20.73%-87.68M | -21.36%-76.71M | -1.25%-293.65M | 50.64%-66.18M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 73.14%-17.08M | 82.27%-15.54M | 57.07%-32.93M | 3.21%-284.23M | 15.03%-56.23M | 30.59%-63.62M | -20.73%-87.68M | -21.36%-76.71M | -1.25%-293.65M | 50.64%-66.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 73.14%-17.08M | 82.27%-15.54M | 57.07%-32.93M | 3.21%-284.23M | 15.03%-56.23M | 30.59%-63.62M | -20.73%-87.68M | -21.36%-76.71M | -1.25%-293.65M | 50.64%-66.18M |
| Basic earnings per share | 73.85%-0.17 | 82.22%-0.16 | 59.26%-0.33 | 7.01%-2.92 | 18.57%-0.57 | 33.67%-0.65 | -15.38%-0.9 | -19.12%-0.81 | 0.00%-3.14 | 51.72%-0.7 |
| Diluted earnings per share | 73.85%-0.17 | 82.22%-0.16 | 59.26%-0.33 | 7.01%-2.92 | 18.57%-0.57 | 33.67%-0.65 | -15.38%-0.9 | -19.12%-0.81 | 0.00%-3.14 | 51.72%-0.7 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
